Nano Holdings, Inc. (TYO:4571)
Japan · Delayed Price · Currency is JPY 77.00
-2.00 (-2.53%)
Oct 26, 2026, 3:30 PM JST
Nano Holdings Company Description
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.
The company’s pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain.
Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material.
The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025.
Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.
Nano Holdings, Inc.
| Country | Japan |
| Founded | 1996 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 23 |
| CEO | Shiro Akinaga |
Contact Details
Address: 2-5-1 Atago Minato Japan | |
| Phone | 81 3 6432 0020 |
| Website | nanomrna.co.jp |
Stock Details
| Ticker Symbol | 4571 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3651120002 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Shiro Akinaga | Chief Executive Officer |
| Koji Fujimoto | Chief Financial Officer |